Quality of life and primary sclerosing cholangitis:: the business of defining what counts

Quality of life and primary sclerosing cholangitis: the business of defining what counts

Katherine Arndtz, Gideon Hirschfield

Research output: Contribution to journal › Editorial › peer-review

3 Citations (Scopus)

198 Downloads (Pure)

Patient reported outcomes; Autoimmune liver disease; Cholangiocarcinoma; clinial trials

Arndzt_&_Hirschield_Qualkity_of_life_and_primary_sclerosing_Hepatology_2018
This is the peer reviewed version of the following article: Arndtz, K. and Hirschfield, G. M. (2018), Quality of life and primary sclerosing cholangitis: The business of defining what counts. Hepatology, 68: 16-18. doi:10.1002/hep.29775, which has been published in final form at 10.1002/hep.29775 . This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Accepted author manuscript, 193 KB

@article{c76bd8dfa8df4034812515ed036be037,

title = "Quality of life and primary sclerosing cholangitis:: the business of defining what counts",

keywords = "Patient reported outcomes; Autoimmune liver disease; Cholangiocarcinoma; clinial trials",

author = "Katherine Arndtz and Gideon Hirschfield",

year = "2018",

month = jul,

day = "1",

doi = "10.1002/hep.29775",

language = "English",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Wiley",

}

TY - JOUR

T1 - Quality of life and primary sclerosing cholangitis:

T2 - the business of defining what counts

AU - Arndtz, Katherine

AU - Hirschfield, Gideon

PY - 2018/7/1

Y1 - 2018/7/1

KW - Patient reported outcomes; Autoimmune liver disease; Cholangiocarcinoma; clinial trials

U2 - 10.1002/hep.29775

DO - 10.1002/hep.29775

M3 - Editorial

SN - 0270-9139

JO - Hepatology

JF - Hepatology

M1 - HEP29775

ER -